8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements

Cencora ($COR) signed a definitive agreement (Mar 21, 2026; announced Mar 23, 2026) to acquire EyeSouth…

Filed with the SEC on · Summarized by InvestorsBot

Cencora ($COR) signed a definitive agreement (Mar 21, 2026; announced Mar 23, 2026) to acquire EyeSouth Partners’ retina business. Press release furnished as Exhibit 99.1 to 8‑K (Reg FD). Parties: Cencora & EyeSouth Partners. 👁️ #M&A #Healthcare

8‑K states the disclosure is furnished, not “filed” (limited Section 18 liability). No purchase price disclosed; deal subject to customary closing conditions & regulatory approvals. Includes forward‑looking statements and related risks. $COR ⚠️ #Investing #EyeCare

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from Cencora, Inc.